Salud financiera de hoja de balance de Kingworld Medicines Group
Salud financiera controles de criterios 5/6
Kingworld Medicines Group tiene un patrimonio de accionistas total de CN¥699.4M y una deuda total de CN¥342.1M, lo que sitúa su ratio deuda-patrimonio en 48.9%. Sus activos y pasivos totales son CN¥1.3B y CN¥638.3M respectivamente. El BAIT de Kingworld Medicines Group es de CN¥78.7M, por lo que su ratio de cobertura de intereses es de -39339. Tiene efectivo e inversiones a corto plazo que ascienden a CN¥194.0M.
Información clave
48.9%
Ratio deuda-patrimonio
CN¥342.13m
Deuda
| Ratio de cobertura de intereses | -39339x |
| Efectivo | CN¥194.03m |
| Patrimonio | CN¥699.35m |
| Total pasivo | CN¥638.30m |
| Activos totales | CN¥1.34b |
Actualizaciones recientes sobre salud financiera
Kingworld Medicines Group (HKG:1110) Seems To Use Debt Rather Sparingly
Apr 24
We Think Kingworld Medicines Group (HKG:1110) Can Stay On Top Of Its Debt
Dec 05Recent updates
Investors Shouldn't Be Too Comfortable With Kingworld Medicines Group's (HKG:1110) Earnings
Apr 29Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0338
Apr 23A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)
Mar 22The Return Trends At Kingworld Medicines Group (HKG:1110) Look Promising
Nov 30Slowing Rates Of Return At Kingworld Medicines Group (HKG:1110) Leave Little Room For Excitement
Aug 17Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0247
May 30The Returns At Kingworld Medicines Group (HKG:1110) Aren't Growing
May 11Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0247
Apr 03Returns On Capital At Kingworld Medicines Group (HKG:1110) Paint A Concerning Picture
Feb 07A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)
Oct 07Kingworld Medicines Group's (HKG:1110) Returns On Capital Not Reflecting Well On The Business
Jul 05Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To HK$0.024
Apr 27We Like These Underlying Return On Capital Trends At Kingworld Medicines Group (HKG:1110)
Aug 17Kingworld Medicines Group (HKG:1110) Seems To Use Debt Rather Sparingly
Apr 24Returns On Capital Are Showing Encouraging Signs At Kingworld Medicines Group (HKG:1110)
Mar 29Kingworld Medicines Group's (HKG:1110) Shareholders Are Down 46% On Their Shares
Mar 08Are Insiders Buying Kingworld Medicines Group Limited (HKG:1110) Stock?
Feb 15Should You Or Shouldn't You: A Dividend Analysis on Kingworld Medicines Group Limited (HKG:1110)
Jan 25
Will the Promising Trends At Kingworld Medicines Group (HKG:1110) Continue?
Dec 18We Think Kingworld Medicines Group (HKG:1110) Can Stay On Top Of Its Debt
Dec 05What We Learned About Kingworld Medicines Group's (HKG:1110) CEO Compensation
Nov 22Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (CN¥588.6M) de 1110 superan a sus pasivos a corto plazo (CN¥463.5M).
Pasivo a largo plazo: Los activos a corto plazo de 1110 (CN¥588.6M) superan a sus pasivos a largo plazo (CN¥174.8M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: El ratio deuda neta-patrimonio (21.2%) de 1110 se considera satisfactorio.
Reducción de la deuda: El ratio deuda-patrimonio de 1110 ha pasado de 52.8% a 48.9% en los últimos 5 años.
Cobertura de la deuda: La deuda de 1110 no está bien cubierta por el flujo de caja operativo (12.4%).
Cobertura de intereses: 1110 gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.